Radiotherapy for Post-Chemotherapy Residual Mass in Advanced Seminoma: A Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography-Based Risk-adapted Approach-Reference-Cited by-同舟云学术

Radiotherapy for Post-Chemotherapy Residual Mass in Advanced Seminoma: A Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography-Based Risk-adapted Approach

Published:2021-07 Issue:7 Volume:33 Page:e315-e321
ISSN:0936-6555
Container-title:Clinical Oncology
language:en
Short-container-title:Clinical Oncology

Author:

Murthy V.,Karmakar S.,Carlton J.,Joshi A.,Krishnatry R.,Prabhash K.,Noronha V.,Bakshi G.,Prakash G.,Pal M.,Menon S.,Agrawal A.,Rangarajan V.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference20 articles.

1. Global incidence and outcome of testicular cancer;Shanmugalingam;Clin Epidemiol,2013

2. [Classification of germ cell tumors of the testis];Droz;Rev Prat,2007

3. a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group;J Clin Oncol,1997

4. Medical treatment of advanced testicular cancer;Feldman;JAMA,2008

5. Advanced seminoma: treatment with cis-platinum-based combination chemotherapy or carboplatin (JM8);Peckham;Br J Cancer,1985

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of post-chemotherapy residual seminomatous masses by 18F-fluorodeoxyglucose PET/CT using tumor-to-liver ratio – conundrum or solution?;Nuclear Medicine Communications;2023-09-14

2. Imaging Recommendations for Diagnosis, Staging, and Management of Testicular Cancer;Indian Journal of Medical and Paediatric Oncology;2023-04

3. Canadian Urological Association consensus guideline: Management of testicular germ cell cancer;Canadian Urological Association Journal;2022-05-31

4. Serum Levels of MicroRNA-371a-3p (M371) Can Predict Absence or Presence of Vital Disease in Residual Masses After Chemotherapy of Metastatic Seminoma;Frontiers in Oncology;2022-05-06